COMPARATIVE STUDY ON THE FORMABILITY OF ALUMINUM 1100 AND BRASS CUZN37 IN SPIF




Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA.4, BA.5 and XBB subvariants dominance in Malaysia: A retrospective cohort study

Objective: To determine if nirmatrelvir-ritonavir 300mg/100mg treatment for 5 days in high-risk outpatients with mild to moderate COVID-19 symptoms was associated with a reduction in hospitalization, intensive care unit (ICU) admission, and death.Methods: This 1:1 propensity score matched cohort study from 647 public ealisboa.com health clinics in

read more